Variant Bio, a genomics-driven AI drug discovery company, today announced the appointment of Craig T. Basson, MD, PhD, as Chief Medical Officer and President of R&D. Dr. Basson brings more than 25 ...
BASEL, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Granite Bio AG, a clinical-stage immunology company, has emerged from stealth with $100 million in funding. This includes a $30 million Series A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results